What is the current valuation of the Animal Model for Testing Market?

The market valuation was 2.09 USD Billion in 2024. Read More

What is the projected market size for the Animal Model for Testing Market by 2035?

The projected valuation for 2035 is 6.018 USD Billion. Read More

What is the expected CAGR for the Animal Model for Testing Market during the forecast period?

The expected CAGR for the market from 2025 to 2035 is 10.09%. Read More

Which companies are considered key players in the Animal Model for Testing Market?

Key players include Charles River Laboratories, Envigo, Taconic Biosciences, and others. Read More

What are the primary segments of the Animal Model for Testing Market?

The market segments include Animal Type, Application, Technology, End-User, and Modality. Read More

How do rodent models perform in terms of market valuation?

Rodent models, specifically mice and rats, had a valuation of 1.045 USD Billion in 2024 and are projected to reach 2.845 USD Billion. Read More

What is the market valuation for non-rodent animal models?

Non-rodent models, including rabbits, dogs, and primates, were valued at 1.045 USD Billion in 2024 and are expected to grow to 3.173 USD Billion. Read More

Which application segment shows the highest growth potential in the market?

The Drug Discovery and Development segment had a valuation of 0.83 USD Billion in 2024 and is projected to reach 2.4 USD Billion. Read More

What is the valuation trend for genetically modified animal models?

Genetically modified animal models were valued at 0.75 USD Billion in 2024 and are expected to grow to 2.25 USD Billion. Read More

How do academic research institutions contribute to the market?

Academic research institutions had a market valuation of 0.21 USD Billion in 2024 and are projected to reach 0.6 USD Billion. Read More

Animal Model For Testing Market

Animal Model for Testing Market Research Report By Animal Type (Rodents (Mice and Rats), Non-Rodents (Rabbits, Dogs, and Primates)), By Application (Drug Discovery and Development, Toxicity Testing, Safety Assessment, Disease Modeling), By Technology (Genetically Modified Animal Models, Non-Genetically Modified Animal Models, Patient-Derived Xenograft (PDX) Models), By End-User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Academic Research Institutions), By Modality (In Vivo, In Vitro, Ex Vivo) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035.

Forecast Period

2025 - 2035

CAGR

10.09%

2024 Market Size

$ 2.09 Billion

2035 Market Size

$ 6.02 Billion

Healthcare ● Updated July 2026 Report ID: MRFR/HC/39411-HCR | Pages: 128 | Author: Rahul Gotadki

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Animal Type (USD Billion)
  1. 4.1.1 Rodents (Mice and Rats)
  2. 4.1.2 Non-Rodents (Rabbits, Dogs, and Primates)
2. 4.2 Healthcare, BY Application (USD Billion)
  1. 4.2.1 Drug Discovery and Development
  2. 4.2.2 Toxicity Testing
  3. 4.2.3 Safety Assessment
  4. 4.2.4 Disease Modeling
3. 4.3 Healthcare, BY Technology (USD Billion)
  1. 4.3.1 Genetically Modified Animal Models
  2. 4.3.2 Non-Genetically Modified Animal Models
  3. 4.3.3 Patient-Derived Xenograft (PDX) Models
4. 4.4 Healthcare, BY End-User (USD Billion)
  1. 4.4.1 Pharmaceutical Companies
  2. 4.4.2 Biotechnology Companies
  3. 4.4.3 Contract Research Organizations (CROs)
  4. 4.4.4 Academic Research Institutions
5. 4.5 Healthcare, BY Modality (USD Billion)
  1. 4.5.1 In Vivo
  2. 4.5.2 In Vitro
  3. 4.5.3 Ex Vivo
6. 4.6 Healthcare, BY Region (USD Billion)
  1. 4.6.1 North America
    1. 4.6.1.1 US
    2. 4.6.1.2 Canada
  2. 4.6.2 Europe
    1. 4.6.2.1 Germany
    2. 4.6.2.2 UK
    3. 4.6.2.3 France
    4. 4.6.2.4 Russia
    5. 4.6.2.5 Italy
    6. 4.6.2.6 Spain
    7. 4.6.2.7 Rest of Europe
  3. 4.6.3 APAC
    1. 4.6.3.1 China
    2. 4.6.3.2 India
    3. 4.6.3.3 Japan
    4. 4.6.3.4 South Korea
    5. 4.6.3.5 Malaysia
    6. 4.6.3.6 Thailand
    7. 4.6.3.7 Indonesia
    8. 4.6.3.8 Rest of APAC
  4. 4.6.4 South America
    1. 4.6.4.1 Brazil
    2. 4.6.4.2 Mexico
    3. 4.6.4.3 Argentina
    4. 4.6.4.4 Rest of South America
  5. 4.6.5 MEA
    1. 4.6.5.1 GCC Countries
    2. 4.6.5.2 South Africa
    3. 4.6.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Charles River Laboratories (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Envigo (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Taconic Biosciences (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Harlan Laboratories (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Crown Bioscience (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Laboratory Corporation of America (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Wuxi AppTec (CN)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Inotiv (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY ANIMAL TYPE
4. 6.4 US MARKET ANALYSIS BY APPLICATION
5. 6.5 US MARKET ANALYSIS BY TECHNOLOGY
6. 6.6 US MARKET ANALYSIS BY END-USER
7. 6.7 US MARKET ANALYSIS BY MODALITY
8. 6.8 CANADA MARKET ANALYSIS BY ANIMAL TYPE
9. 6.9 CANADA MARKET ANALYSIS BY APPLICATION
10. 6.10 CANADA MARKET ANALYSIS BY TECHNOLOGY
11. 6.11 CANADA MARKET ANALYSIS BY END-USER
12. 6.12 CANADA MARKET ANALYSIS BY MODALITY
13. 6.13 EUROPE MARKET ANALYSIS
14. 6.14 GERMANY MARKET ANALYSIS BY ANIMAL TYPE
15. 6.15 GERMANY MARKET ANALYSIS BY APPLICATION
16. 6.16 GERMANY MARKET ANALYSIS BY TECHNOLOGY
17. 6.17 GERMANY MARKET ANALYSIS BY END-USER
18. 6.18 GERMANY MARKET ANALYSIS BY MODALITY
19. 6.19 UK MARKET ANALYSIS BY ANIMAL TYPE
20. 6.20 UK MARKET ANALYSIS BY APPLICATION
21. 6.21 UK MARKET ANALYSIS BY TECHNOLOGY
22. 6.22 UK MARKET ANALYSIS BY END-USER
23. 6.23 UK MARKET ANALYSIS BY MODALITY
24. 6.24 FRANCE MARKET ANALYSIS BY ANIMAL TYPE
25. 6.25 FRANCE MARKET ANALYSIS BY APPLICATION
26. 6.26 FRANCE MARKET ANALYSIS BY TECHNOLOGY
27. 6.27 FRANCE MARKET ANALYSIS BY END-USER
28. 6.28 FRANCE MARKET ANALYSIS BY MODALITY
29. 6.29 RUSSIA MARKET ANALYSIS BY ANIMAL TYPE
30. 6.30 RUSSIA MARKET ANALYSIS BY APPLICATION
31. 6.31 RUSSIA MARKET ANALYSIS BY TECHNOLOGY
32. 6.32 RUSSIA MARKET ANALYSIS BY END-USER
33. 6.33 RUSSIA MARKET ANALYSIS BY MODALITY
34. 6.34 ITALY MARKET ANALYSIS BY ANIMAL TYPE
35. 6.35 ITALY MARKET ANALYSIS BY APPLICATION
36. 6.36 ITALY MARKET ANALYSIS BY TECHNOLOGY
37. 6.37 ITALY MARKET ANALYSIS BY END-USER
38. 6.38 ITALY MARKET ANALYSIS BY MODALITY
39. 6.39 SPAIN MARKET ANALYSIS BY ANIMAL TYPE
40. 6.40 SPAIN MARKET ANALYSIS BY APPLICATION
41. 6.41 SPAIN MARKET ANALYSIS BY TECHNOLOGY
42. 6.42 SPAIN MARKET ANALYSIS BY END-USER
43. 6.43 SPAIN MARKET ANALYSIS BY MODALITY
44. 6.44 REST OF EUROPE MARKET ANALYSIS BY ANIMAL TYPE
45. 6.45 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
46. 6.46 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY
47. 6.47 REST OF EUROPE MARKET ANALYSIS BY END-USER
48. 6.48 REST OF EUROPE MARKET ANALYSIS BY MODALITY
49. 6.49 APAC MARKET ANALYSIS
50. 6.50 CHINA MARKET ANALYSIS BY ANIMAL TYPE
51. 6.51 CHINA MARKET ANALYSIS BY APPLICATION
52. 6.52 CHINA MARKET ANALYSIS BY TECHNOLOGY
53. 6.53 CHINA MARKET ANALYSIS BY END-USER
54. 6.54 CHINA MARKET ANALYSIS BY MODALITY
55. 6.55 INDIA MARKET ANALYSIS BY ANIMAL TYPE
56. 6.56 INDIA MARKET ANALYSIS BY APPLICATION
57. 6.57 INDIA MARKET ANALYSIS BY TECHNOLOGY
58. 6.58 INDIA MARKET ANALYSIS BY END-USER
59. 6.59 INDIA MARKET ANALYSIS BY MODALITY
60. 6.60 JAPAN MARKET ANALYSIS BY ANIMAL TYPE
61. 6.61 JAPAN MARKET ANALYSIS BY APPLICATION
62. 6.62 JAPAN MARKET ANALYSIS BY TECHNOLOGY
63. 6.63 JAPAN MARKET ANALYSIS BY END-USER
64. 6.64 JAPAN MARKET ANALYSIS BY MODALITY
65. 6.65 SOUTH KOREA MARKET ANALYSIS BY ANIMAL TYPE
66. 6.66 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
67. 6.67 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY
68. 6.68 SOUTH KOREA MARKET ANALYSIS BY END-USER
69. 6.69 SOUTH KOREA MARKET ANALYSIS BY MODALITY
70. 6.70 MALAYSIA MARKET ANALYSIS BY ANIMAL TYPE
71. 6.71 MALAYSIA MARKET ANALYSIS BY APPLICATION
72. 6.72 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY
73. 6.73 MALAYSIA MARKET ANALYSIS BY END-USER
74. 6.74 MALAYSIA MARKET ANALYSIS BY MODALITY
75. 6.75 THAILAND MARKET ANALYSIS BY ANIMAL TYPE
76. 6.76 THAILAND MARKET ANALYSIS BY APPLICATION
77. 6.77 THAILAND MARKET ANALYSIS BY TECHNOLOGY
78. 6.78 THAILAND MARKET ANALYSIS BY END-USER
79. 6.79 THAILAND MARKET ANALYSIS BY MODALITY
80. 6.80 INDONESIA MARKET ANALYSIS BY ANIMAL TYPE
81. 6.81 INDONESIA MARKET ANALYSIS BY APPLICATION
82. 6.82 INDONESIA MARKET ANALYSIS BY TECHNOLOGY
83. 6.83 INDONESIA MARKET ANALYSIS BY END-USER
84. 6.84 INDONESIA MARKET ANALYSIS BY MODALITY
85. 6.85 REST OF APAC MARKET ANALYSIS BY ANIMAL TYPE
86. 6.86 REST OF APAC MARKET ANALYSIS BY APPLICATION
87. 6.87 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY
88. 6.88 REST OF APAC MARKET ANALYSIS BY END-USER
89. 6.89 REST OF APAC MARKET ANALYSIS BY MODALITY
90. 6.90 SOUTH AMERICA MARKET ANALYSIS
91. 6.91 BRAZIL MARKET ANALYSIS BY ANIMAL TYPE
92. 6.92 BRAZIL MARKET ANALYSIS BY APPLICATION
93. 6.93 BRAZIL MARKET ANALYSIS BY TECHNOLOGY
94. 6.94 BRAZIL MARKET ANALYSIS BY END-USER
95. 6.95 BRAZIL MARKET ANALYSIS BY MODALITY
96. 6.96 MEXICO MARKET ANALYSIS BY ANIMAL TYPE
97. 6.97 MEXICO MARKET ANALYSIS BY APPLICATION
98. 6.98 MEXICO MARKET ANALYSIS BY TECHNOLOGY
99. 6.99 MEXICO MARKET ANALYSIS BY END-USER
100. 6.100 MEXICO MARKET ANALYSIS BY MODALITY
101. 6.101 ARGENTINA MARKET ANALYSIS BY ANIMAL TYPE
102. 6.102 ARGENTINA MARKET ANALYSIS BY APPLICATION
103. 6.103 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY
104. 6.104 ARGENTINA MARKET ANALYSIS BY END-USER
105. 6.105 ARGENTINA MARKET ANALYSIS BY MODALITY
106. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY ANIMAL TYPE
107. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
108. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
109. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USER
110. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY MODALITY
111. 6.111 MEA MARKET ANALYSIS
112. 6.112 GCC COUNTRIES MARKET ANALYSIS BY ANIMAL TYPE
113. 6.113 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
114. 6.114 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY
115. 6.115 GCC COUNTRIES MARKET ANALYSIS BY END-USER
116. 6.116 GCC COUNTRIES MARKET ANALYSIS BY MODALITY
117. 6.117 SOUTH AFRICA MARKET ANALYSIS BY ANIMAL TYPE
118. 6.118 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
119. 6.119 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY
120. 6.120 SOUTH AFRICA MARKET ANALYSIS BY END-USER
121. 6.121 SOUTH AFRICA MARKET ANALYSIS BY MODALITY
122. 6.122 REST OF MEA MARKET ANALYSIS BY ANIMAL TYPE
123. 6.123 REST OF MEA MARKET ANALYSIS BY APPLICATION
124. 6.124 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY
125. 6.125 REST OF MEA MARKET ANALYSIS BY END-USER
126. 6.126 REST OF MEA MARKET ANALYSIS BY MODALITY
127. 6.127 KEY BUYING CRITERIA OF HEALTHCARE
128. 6.128 RESEARCH PROCESS OF MRFR
129. 6.129 DRO ANALYSIS OF HEALTHCARE
130. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
131. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
132. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
133. 6.133 HEALTHCARE, BY ANIMAL TYPE, 2024 (% SHARE)
134. 6.134 HEALTHCARE, BY ANIMAL TYPE, 2024 TO 2035 (USD Billion)
135. 6.135 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
136. 6.136 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
137. 6.137 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
138. 6.138 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
139. 6.139 HEALTHCARE, BY END-USER, 2024 (% SHARE)
140. 6.140 HEALTHCARE, BY END-USER, 2024 TO 2035 (USD Billion)
141. 6.141 HEALTHCARE, BY MODALITY, 2024 (% SHARE)
142. 6.142 HEALTHCARE, BY MODALITY, 2024 TO 2035 (USD Billion)
143. 6.143 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.2.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.2.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.2.5 BY MODALITY, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.3.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.3.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.3.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.3.5 BY MODALITY, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.4.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.4.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.4.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.4.5 BY MODALITY, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.5.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.5.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.5.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.5.5 BY MODALITY, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.6.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.6.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.6.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.6.5 BY MODALITY, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.7.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.7.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.7.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.7.5 BY MODALITY, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.8.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.8.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.8.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.8.5 BY MODALITY, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.9.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.9.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.9.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.9.5 BY MODALITY, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.10.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.10.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.10.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.10.5 BY MODALITY, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.11.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.11.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.11.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.11.5 BY MODALITY, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.12.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.12.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.12.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.12.5 BY MODALITY, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.13.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.13.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.13.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.13.5 BY MODALITY, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.14.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.14.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.14.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.14.5 BY MODALITY, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.15.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.15.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.15.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.15.5 BY MODALITY, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.16.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.16.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.16.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.16.5 BY MODALITY, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.17.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.17.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.17.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.17.5 BY MODALITY, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.18.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.18.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.18.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.18.5 BY MODALITY, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.19.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.19.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.19.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.19.5 BY MODALITY, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.20.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.20.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.20.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.20.5 BY MODALITY, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.21.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.21.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.21.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.21.5 BY MODALITY, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.22.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.22.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.22.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.22.5 BY MODALITY, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.23.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.23.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.23.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.23.5 BY MODALITY, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.24.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.24.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.24.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.24.5 BY MODALITY, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.25.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.25.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.25.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.25.5 BY MODALITY, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.26.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.26.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.26.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.26.5 BY MODALITY, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.27.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.27.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.27.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.27.5 BY MODALITY, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.28.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.28.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.28.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.28.5 BY MODALITY, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.29.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.29.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.29.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.29.5 BY MODALITY, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  2. 7.30.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.30.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.30.4 BY END-USER, 2025-2035 (USD Billion)
  5. 7.30.5 BY MODALITY, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Animal Model For Testing Market Segmentation

Animal Model For Testing Market By Animal Type (USD Billion, 2025-2035)

Rodents (Mice and Rats)
Non-Rodents (Rabbits, Dogs, and Primates)

Animal Model For Testing Market By Application (USD Billion, 2025-2035)

Drug Discovery and Development
Toxicity Testing
Safety Assessment
Disease Modeling

Animal Model For Testing Market By Technology (USD Billion, 2025-2035)

Genetically Modified Animal Models
Non-Genetically Modified Animal Models
Patient-Derived Xenograft (PDX) Models

Animal Model For Testing Market By End-User (USD Billion, 2025-2035)

Animal Model For Testing Market Companies
Biotechnology Companies
Contract Research Organizations (CROs)
Academic Research Institutions

Animal Model For Testing Market By Modality (USD Billion, 2025-2035)

In Vivo
In Vitro
Ex Vivo

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”